Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Brenner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research|July 1, 1995
Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cellsA J Brenner, C M Aldaz
Analytical Biochemistry|March 20, 1995
A quantitative test for copper using bicinchoninic acidA J Brenner, E D Harris
Progress in Clinical and Biological Research|January 1, 1997
The genetics of sporadic breast cancerA J Brenner, C M Aldaz
Oncogene|July 23, 1998
Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivationA J Brenner, M R Stampfer, C M Aldaz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stageA K Bednarek, A Sahin, A J Brenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1996
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancerA J Brenner, A Paladugu, H Wang, et al.
Cancer Research|November 24, 2001
WWOX, the FRA16D gene, behaves as a suppressor of tumor growthA K Bednarek, C L Keck-Waggoner, R L Daniel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research|July 1, 1995
Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cellsA J Brenner, C M Aldaz
Analytical Biochemistry|March 20, 1995
A quantitative test for copper using bicinchoninic acidA J Brenner, E D Harris
Progress in Clinical and Biological Research|January 1, 1997
The genetics of sporadic breast cancerA J Brenner, C M Aldaz
Oncogene|July 23, 1998
Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivationA J Brenner, M R Stampfer, C M Aldaz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stageA K Bednarek, A Sahin, A J Brenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1996
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancerA J Brenner, A Paladugu, H Wang, et al.
Cancer Research|November 24, 2001
WWOX, the FRA16D gene, behaves as a suppressor of tumor growthA K Bednarek, C L Keck-Waggoner, R L Daniel, et al.
Pageof 1